TickerFactsScreenerDevelopers

Denali Therapeutics Inc. (DNLI) — Total Liabilities

Annual figures by fiscal year, from SEC filings.

2017: $20.93M2018: $115.14M2019: $158.34M2020: $453.75M2021: $441.87M2022: $417.81M2023: $122.96M2024: $144.50M2025: $131.09M$131.09M
2017Total Liabilities (USD)2025
Fiscal YearTotal LiabilitiesChange YoY
2025$131.09M-9.3%
2024$144.50M+17.5%
2023$122.96M-70.6%
2022$417.81M-5.4%
2021$441.87M-2.6%
2020$453.75M+186.6%
2019$158.34M+37.5%
2018$115.14M+450.2%
2017$20.93M—